Navigation Links
The science of design
Date:4/9/2009

Some women would kill for a great pair of Manolos. Some men would easily pay more than $100 for a pair of Jordans. But what about a new pair of McGuire and Whitneys?

Temple podiatrists James McGuire and Kendrick Whitney recently joined the shoe design business with the release of their R'n'R rest and recovery shoe, the first commercially available shoe to be designed by university-backed researchers.

The R'n'R is a product of Creative Footwear Technology, a venture between the two doctors and local entrepreneur Richard Posoff that uses the latest in foot and ankle research to produce a foot-friendly therapeutic shoe.

"Most shoes on the market today are designed by artists and not scientists who know something about how the foot works," said McGuire. "Our goal was to enhance the way shoes are designed, by looking at research-based findings and put out a better shoe, one that's designed with both function and form in mind."

Commercially available shoes tend to place the most support on the arch of the foot, which throws off the body's center of gravity and keeps the foot from functioning normally. McGuire and Whitney say that the R'n'R offers an entirely new way to support the arch, and it dissipates the shock and stress experienced at the two most stressful parts of the gait cycle: heel strike and pushoff. As a result, the shoes provide a more natural gait, reduce shock and shear forces, and support the foot while still allowing a natural use of the muscles and bones.

Whitney said the shoe is a reflection of the industry's shift away from orthotic inserts that are designed to restrict foot movement.

"We want the foot to work normally, as if it was a bare foot, as nature intended," he said. "This shoe is designed to allow for a more natural function with enhanced comfort for a harsh environment."

Together, McGuire and Whitney have developed more than 30 footwear and foot care products to meet their patients' needs, but the R'n'R is their first to be sold over the counter in retail stores.

Temple's Office of Strategic Initiatives and Corporate Partnerships facilitated the business partnership, with due diligence and business plan advice provided by BioStrategy Partners in Philadelphia. Market research and business plan assistance was provided by the Fox School of Business.

"Creative Footwear Technology represents another example of Temple's commitment to support entrepreneurial efforts by its faculty," said Larry Lemanski, the university's senior vice president for research and strategic initiatives. "The company's partnership with our Office of Technology Transfer, Office of Strategic Initiatives and Corporate Partnerships, the Fox School of Business and BioStrategy Partners demonstrates how society can benefit when industry and academia work together in applying scientific findings to solve real-life problems."


'/>"/>

Contact: Renee Cree
rencree@temple.edu
215-707-1583
Temple University
Source:Eurekalert  

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
3. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. SAMHSA Announces First Science and Service Award Winners
10. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
11. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The science of design
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “I Forgive You”: a fine examination of ... Forgive You” is the creation of published author, Stephen Miller, who, for over ten long ... gracefully given to him. Born in Trinidad and Tobago, he has been serving the Lord ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a ... author, Sara Seymour, who lives in Lafayette, Indiana where she works in a daycare ... coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, ... and poetry collections. , “I have been writing since high school and have ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All ... is the creation of published author, Keith C. A. Tucker, son of Minister Delores ... World Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 20, 2017 Research and Markets has ... Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive ... Segment Forecasts, 2013 - 2024" report to their offering. ... The global clinical ... 2024 Introduction of innovative solutions on the grounds of ...
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, a ... announced the launch of an opioid management program ... on opioids and helps stem the growing tide ... prescribed to treat chronic non-cancer pain (back pain, ... risks and lack of evidence regarding long-term effectiveness. ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
Breaking Medicine Technology: